Eliprodil is primarily studied for its potential therapeutic applications in the field of neuroscience, particularly in addressing conditions related to brain injury and neurodegenerative diseases. It functions as an NMDA receptor antagonist, which helps in regulating the activity of glutamate, a neurotransmitter involved in brain signaling. By modulating glutamate's effects, Eliprodil shows promise in protecting neurons from excessive excitation that can lead to cell damage or death. This makes it a candidate for treating stroke, traumatic brain injury, and certain types of epilepsy. Additionally, its neuroprotective properties are being explored for potential use in combating diseases like Alzheimer's and Parkinson's, where neuronal damage plays a critical role. Research is ongoing to fully understand its efficacy and safety in clinical settings.